Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Cash Flows

v3.23.3
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash Flows from Operating Activities:    
Net (loss) income $ (4,457,396) $ 5,528,308
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Income from cash and investments held in Trust Account (1,829,595) (1,038,563)
Change in fair value of derivative warrant liabilities 295,500 (5,417,500)
Change in fair value of working capital loan - related party (800)
Stock compensation expense 3,483,444
Gain from extinguishment of deferred underwriting commissions (362,250)
Changes in operating assets and liabilities:    
Prepaid expenses (1,645) 85,416
Accounts payable 1,723,402 (12,883)
Accrued expenses 550,980 365,593
Deferred legal fees 8,210
Net cash used in operating activities (598,360) (481,419)
Cash Flows from Investing Activities:    
Cash withdrawn from Trust Account in connection with redemption 273,410,361
Net cash provided by investing activities 273,410,361
Cash Flows from Financing Activities:    
Redemption of Class A ordinary shares (273,410,361)  
Proceeds from issuance of working capital loan to related party 594,000
Offering costs paid (75,000)
Net cash used in financing activities (272,816,361) (75,000)
Net change in cash (4,360) (556,419)
Cash - beginning of the period 21,548 562,346
Cash - end of the period 17,188 5,927
Supplemental disclosure of noncash financing activities:    
Accounts payable paid by the Sponsor 20,930
Forgiveness of deferred underwriting fee payable allocated to Class A ordinary shares $ 9,700,250